1,011 research outputs found

    Intensity of Brillouin light scattering from spin waves in magnetic multilayers with noncollinear spin configurations: Theory and experiment

    Full text link
    The scattering of photons from spin waves (Brillouin light scattering -- BLS) is a well-established technique for the study of layered magnetic systems. The information about the magnetic state and properties of the sample is contained in the frequency position, width, and intensity of the BLS peaks. Previously [Phys. Rev. B 67, 184404 (2003)], we have shown that spin wave frequencies can be conveniently calculated within the ultrathin film approach, treating the intralayer exchange as an effective bilinear interlayer coupling between thin virtual sheets of the ferromagnetic layers. Here we give the consequent extension of this approach to the calculation of the Brillouin light scattering (BLS) peak intensities. Given the very close relation of the BLS cross-section to the magneto-optic Kerr effect (MOKE), the depth-resolved longitudinal and polar MOKE coefficients calculated numerically via the usual magneto-optic formalism can be employed in combination with the spin wave precessional amplitudes to calculate full BLS spectra for a given magnetic system. This approach allows an easy calculation of BLS intensities even for noncollinear spin configurations including the exchange modes. The formalism is applied to a Fe/Cr/Fe/Ag/Fe trilayer system with one antiferromagnetically coupling spacer (Cr). Good agreement with the experimental spectra is found for a wide variety of spin configurations.Comment: 19 pages, 5 figure

    In flight performance and first results of FREGATE

    Full text link
    The gamma-ray detector of HETE-2, called FREGATE, has been designed to detect gamma-ray bursts in the energy range [6-400] keV. Its main task is to alert the other instruments of the occurrence of a gamma-ray burst (GRB) and to provide the spectral coverage of the GRB prompt emission in hard X-rays and soft gamma-rays. FREGATE was switched on on October 16, 2000, one week after the successful launch of HETE-2, and has been continuously working since then. We describe here the main characteristics of the instrument, its in-flight performance and we briefly discuss the first GRB observations.Comment: Invited lecture at the Woods Hole 2001 GRB Conference, 8 pages, 15 figure

    HETE-II and the Interplanetary Network

    Get PDF
    The FREGATE experiment aboard HETE-II has been successfully integrated into the Third Interplanetary Network (IPN) of gamma-ray burst detectors. We show how HETE's timing has been verified in flight, and discuss what HETE can do for the IPN and vice-versa.Comment: To appear in the proceedings of the conference on Gamma-Ray Burst and Afterglow Astronomy 2001: A Workshop Celebrating the First Year of the HETE Mission, to be published by AIP. Figures must be downloaded and printed separatel

    Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression

    Get PDF
    Vascular endothelial growth factor (VEGF) is an important factor mediating tumour angiogenesis. VEGF mRNA is differentially expressed in bladder cancer with high expression in superficial tumours (stage pTaand pT1) contrasting with low expression in muscle invasive tumours (stage ≥ pT2). To investigate mechanisms regulating VEGF expression in bladder cancer, VEGF mRNA and protein were measured in normal bladder (n = 12) and primary bladder cancers (n = 57). VEGF protein levels correlated with mRNA expression in normal bladder (r = 0.68, P = 0.02) and bladder cancer (r = 0.46, P = 0.0007). Whilst VEGF mRNA expression was threefold higher in superficial compared to muscle invasive bladder cancers (P = 0.0001) there was no difference in VEGF protein (P = 0.81). Accordingly, the median protein:mRNA ratios increased more than 15-fold with increasing tumour stage (P< 0.0001) suggesting translational regulation. Expression of the eukaryotic initiation factor-4E (eIF-4E), a factor implicated in the translational regulation of VEGF, was greater in tumours than normal bladder (P< 0.0001) and correlated with VEGF protein:mRNA ratios (n = 43, r = 0.54, P = 0.0004) pointing to its role in the regulation of VEGF. In superficial tumours (n = 37) high expression of eIF-4E was associated with a poor prognosis and reduced stage progression-free survival (P = 0.04, Cox proportional hazards model). The study demonstrates that eIF-4E may be involved in translational regulation of VEGF in bladder cancer and might have a role as a prognostic factor in bladder cancer. © 2000 Cancer Research Campaig

    Time-resolved X-ray spectral modeling of an intermediate burst from SGR1900+14 observed by HETE-2/FREGATE and WXM

    Get PDF
    We present a detailed analysis of a 3.5 s long burst from SGR 1900+14 that occurred on 2001 July 2. The 2-150 keV time-integrated energy spectrum is well described by the sum of two blackbodies whose temperatures are approximately 4.3 and 9.8 keV. The time-resolved energy spectra are similarly well fitted by the sum of two blackbodies. The higher temperature blackbody evolves with time in a manner consistent with a shrinking emitting surface. The interpretation of these results in the context of the magnetar model suggests that the two-blackbody fit is an approximation of an absorbed, multitemperature spectrum expected on theoretical grounds rather than a physical description of the emission. If this is indeed the case, our data provide further evidence for a strong magnetic field and indicate that the entire neutron star was radiating during most of the burst duration

    The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer

    Get PDF
    Regulation by hypoxia may underlie the expression of vascular endothelial growth factor in bladder cancer. We have compared the distribution of vascular endothelial growth factor mRNA with a hypoxia marker, carbonic anhydrase 9 (CA IX). vascular endothelial growth factor mRNA was analysed by in situ hybridisation and CA IX by immunochemistry in 22 cases of bladder cancer. The relationship of microvessels to the distribution of CA IX was determined. In a separate series of 49 superficial tumours, CA IX immunostaining was compared with clinico-pathological outcome. In superficial and invasive disease there was overlap in the expression of vascular endothelial growth factor and CA IX, CA IX being more widespread. Both were expressed predominantly on the luminal surface, and surrounding areas of necrosis (invasive tumours). Expression of both factors was greater in superficial disease. Expression was absent within ∼80 μm of microvessels. Unlike vascular endothelial growth factor, CA IX did not predict outcome in superficial disease. Differential responses to reoxygenation provide one explanation: vascular endothelial growth factor mRNA declined rapidly, while CA IX expression was sustained for >72 h. Expression of vascular endothelial growth factor mRNA in bladder tumours is consistent with hypoxic regulation and suggests differential regulation in superficial vs invasive disease. The expression of CA IX on the luminal surface justifies investigation of its utility as a therapeutic target/prognostic indicator
    corecore